# Hepatitis C Virus Donor Positive Kidney Transplantation for Hepatitis C Virus Negative Recipients

> **NCT03249194** · EARLY_PHASE1 · COMPLETED · sponsor: **Virginia Commonwealth University** · enrollment: 25 (actual)

## Conditions studied

- Kidney Transplant
- Hepatitis C

## Interventions

- **DRUG:** Direct acting Anti-Viral Therapy using Epclusa or Zepatier

## Key facts

- **NCT ID:** NCT03249194
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-17
- **Primary completion:** 2020-03-15
- **Final completion:** 2020-03-15
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2020-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03249194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03249194, "Hepatitis C Virus Donor Positive Kidney Transplantation for Hepatitis C Virus Negative Recipients". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03249194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*